Risk of continuous using of LDA for intraoperative bleeding during gastric endoscopic gastric dissection

Risk of continuous using of LDA for intraoperative bleeding during gastric endoscopic gastric dissection - Risk of continuous using of LDA for intraoperative bleeding during gastric endoscopic gastric dissection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024611

Enrollment

200

Registered

2016-11-01

Start date

2016-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the expanded criteria of ESD

Exclusion criteria

Exclusion criteria: (1) had a history of prior surgery; (2) received plural antiplatelet therapy; (3) received anticoagulant therapy

Design outcomes

Primary

Measure	Time frame
the frequency of intraoperative major bleeding	—

Secondary

Measure	Time frame
procedure time, en bloc resection rate, and adverse events rate	—

Countries

Japan

Contacts

Public ContactYohei Horikawa

Hiraka General Hospital Gastroenterology

horikawa_01@me.com0182-32-5121

Outcome results